- Ghana has seen disturbing increases in the active case count since the beginning of this year
- The country is expected to take delivery of some 17million doses of the vaccines by June
- It has been warned that the world can only return to normal times with a wide coverage of the vaccines
Our manifesto: This is what YEN.com.gh believes in
COVID-19 has killed eight more people in Ghana, bringing the country’s death toll to 472.
A total of 795 new cases were also recorded, shooting up the active case count to 6707, according to the Ghana Health Service (GHS) website.
Ghana has now recorded 73,328 cases with a total of 65,149 recoveries.
There are currently over 150 persons in severe and critical conditions respectively.
Below is the regional breakdown as of the time of filing this report.
Greater Accra Region - 42,312
Ashanti Region - 13,092
Western Region - 4,043
Eastern Region - 3,109
Central Region - 2,458
Volta Region - 1,131
Bono East Region - 882
Northern Region - 802
Upper East Region - 755
Western North Region - 729
Bono Region - 705
Ahafo Region - 563
Oti Region - 250
Upper West Region - 239
Savannah Region - 68
North East Region - 37
A member of the WHO's committee for COVID-19, Prof Helen Rees, warned that the world will only return to normal times well into 2022.
"I think this new normal we all talk about is with us for a very long time,” Rees told the BBC.
A herbal medicine, Cryptolepis sanguinolenta, was approved for a clinical trial in Ghana for the treatment of COVID-19.
Known locally as ‘Nibima’, Cryptolepis sanguinolenta's approval for the trial was announced on Monday, February 1, 2021, by the Food and Drugs Authority (FDA).
The herbal medicine developed by the School of Public Health at the Kwame Nkrumah University of Science and Technology (KNUST) was submitted to the FDA for the clinical trial in September 2020 and approval was granted in January 2021.
Ghana is set to receive the first batch of over 17 million vaccines the country is expecting in March 2021.
The country was earmarked as one of the 145 counties of the UN-led COVAX facility to take delivery of 2.4 million doses of the AstraZeneca vaccine which is licensed to the Serum Institute of India (AZ/SII).
The delivery is estimated to begin before the end of February.
The vaccine is expected to be administered to persons in key sectors such as health workers in the first quarter.
Enjoy reading our stories?
Download YEN's news app on Google Play now and stay up-to-date with major Ghana news!
Source: Yen Newspaper